Current stage?-Stage I - Page 8 of 24 Posts on Medivizor
Navigation Menu

Current stage?-Stage I Posts on Medivizor

The pre-operative use of accelerated partial breast irradiation in treating early-stage breast cancer

The pre-operative use of accelerated partial breast irradiation in treating early-stage breast cancer

Posted by on Apr 13, 2017 in Breast cancer | 0 comments

In a nutshell This study investigated whether accelerated partial-breast irradiation (APBI) was useful for preoperative treatment of early-stage breast cancer (BC) patients. APBI was found to be an effective treatment option with good cosmetic results for certain early-stage BC patients. Some background Breast conserving therapy (surgery to remove...

Read More

The timing of first biopsy and its effect on prostate cancer reclassification

The timing of first biopsy and its effect on prostate cancer reclassification

Posted by on Apr 3, 2017 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine the influence of biopsy timing on prostate cancer reclassification during active surveillance.  The authors concluded that the timing of the first biopsy was not related to an increased risk of cancer reclassification, but prostate specific antigen (PSA) and body mass index (BMI – measured based...

Read More

The impact of exercise on the risk of cardiovascular events in women with non-metastatic breast cancer

The impact of exercise on the risk of cardiovascular events in women with non-metastatic breast cancer

Posted by on Mar 20, 2017 in Breast cancer | 0 comments

In a nutshell This study investigated whether exercise was associated with a reduction in the risk of cardiovascular disease (CVD) in patients with non-metastatic breast cancer (BC). Exercise was found to be linked to a significant reduction in the risk of CVD for this patient group. Some background CVD is a leading cause of death among women with...

Read More

Extended adjuvant therapy in hormone-receptor-positive early breast cancer

Extended adjuvant therapy in hormone-receptor-positive early breast cancer

Posted by on Jan 21, 2017 in Breast cancer | 0 comments

In a nutshell This review examined the benefits of extending hormone therapy from 5 to 10 years in patients with hormone receptor positive breast cancer. The study concluded that treatment recommendations should take factors such as previous treatments and potential side effects into account. Some background Hormone-receptor (HR)-positive breast...

Read More